Table of Content

Table of Contents

Global Parkinson's Disease Treatment Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Levodopa/carbidopa -Product Introduction and Major Manufacturers
1.1.2 Dopamine Receptor Agonists -Product Introduction and Major Manufacturers
1.1.3 MAO-Inhibitors -Product Introduction and Major Manufacturers
1.1.4 COMT-inhibitors -Product Introduction and Major Manufacturers
1.1.5 Anticholinergics -Product Introduction and Major Manufacturers
1.1.6 Other Drugs -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.1.1 China Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.1.2 China Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.2.1 EU Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.2.2 EU Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.3.1 USA Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.3.2 USA Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.4.1 Japan Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.4.2 Japan Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.5.1 India Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.5.2 India Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.6.1 Southeast Asia Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.7.1 South America Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.7.2 South America Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Parkinson's Disease Treatment Status and Prospect (2015-2026)
2.8.1 Parkinson's Disease Treatment Market Size and Growth Rate (2015-2026)
2.8.2 Parkinson's Disease Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Parkinson's Disease Treatment Market Assessment by Segment
3.1 Global Parkinson's Disease Treatment Capacity and Growth Rate
3.2 Global Parkinson's Disease Treatment Sales by Type
3.3 Global Parkinson's Disease Treatment Sales Revenue by Type
3.4 Global Parkinson's Disease Treatment Consumption by Application
4 Global Parkinson's Disease Treatment Market Assessment by Regions
4.1 Global Parkinson's Disease Treatment Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Parkinson's Disease Treatment Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Parkinson's Disease Treatment Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Parkinson's Disease Treatment Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Parkinson's Disease Treatment Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Parkinson's Disease Treatment Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Parkinson's Disease Treatment Sales Market Share of Manufacturers (2019-2020)
6.3 Global Parkinson's Disease Treatment Sales Revenue Market Share of Manufacturers (2019-2020)

7 Parkinson's Disease Treatment Competitive Analysis
7.1 Teva (Israel)
7.1.1 Teva (Israel) Company Profiles
7.1.2 Teva (Israel) Product Introduction
7.1.3 Teva (Israel) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Novartis AG (Switzerland)
7.2.1 Novartis AG (Switzerland) Company Profiles
7.2.2 Novartis AG (Switzerland) Product Introduction
7.2.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 GSK (UK)
7.3.1 GSK (UK) Company Profiles
7.3.2 GSK (UK) Product Introduction
7.3.3 GSK (UK) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 AbbVie (US)
7.4.1 AbbVie (US) Company Profiles
7.4.2 AbbVie (US) Product Introduction
7.4.3 AbbVie (US) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Merck (US)
7.5.1 Merck (US) Company Profiles
7.5.2 Merck (US) Product Introduction
7.5.3 Merck (US) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Boehringer Ingelheim (Germany)
7.6.1 Boehringer Ingelheim (Germany) Company Profiles
7.6.2 Boehringer Ingelheim (Germany) Product Introduction
7.6.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Impax Laboratories (US)
7.7.1 Impax Laboratories (US) Company Profiles
7.7.2 Impax Laboratories (US) Product Introduction
7.7.3 Impax Laboratories (US) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Lundbeck (Denmark)
7.8.1 Lundbeck (Denmark) Company Profiles
7.8.2 Lundbeck (Denmark) Product Introduction
7.8.3 Lundbeck (Denmark) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 UCB (Belgium)
7.9.1 UCB (Belgium) Company Profiles
7.9.2 UCB (Belgium) Product Introduction
7.9.3 UCB (Belgium) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Valeant Pharmaceuticals (Canada)
7.10.1 Valeant Pharmaceuticals (Canada) Company Profiles
7.10.2 Valeant Pharmaceuticals (Canada) Product Introduction
7.10.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Acadia (US)
7.12 Sun Pharma (India)
7.13 Wockhardt (India)
7.14 Dr. Reddy's (India)
7.15 Intas (India)
7.16 US WorldMeds (US)
7.17 Zydus Cadila (India)
7.18 Cipla (India)
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Parkinson's Disease Treatment Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Parkinson's Disease Treatment Sales (K Unit) by Type (2015-2026)
Figure Global Parkinson's Disease Treatment Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Parkinson's Disease Treatment Sales Market Share (%) by Type (2019 -2020)
Table Global Parkinson's Disease Treatment Sales Value (Million USD) by Type (2015-2026)
Figure Global Parkinson's Disease Treatment Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Parkinson's Disease Treatment Sales Value Market Share (%) by Type (2019-2020)
Table Global Parkinson's Disease Treatment Sales (K Unit) by Application (2015-2026)
Figure China Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table China Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table India Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Parkinson's Disease Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Parkinson's Disease Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Parkinson's Disease Treatment Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Parkinson's Disease Treatment Capacity (K Units) and Growth Rate (2015-2026)
Table Global Parkinson's Disease Treatment Sales (Unit) by Type (2015-2026)
Figure Global Parkinson's Disease Treatment Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Parkinson's Disease Treatment Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Parkinson's Disease Treatment Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Parkinson's Disease Treatment Consumption (Unit) by Application (2015-2026)
Figure Global Parkinson's Disease Treatment Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Parkinson's Disease Treatment Production (K Unite) by Regions (2015-2020)
Table Global Parkinson's Disease Treatment CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Parkinson's Disease Treatment Production Share by Regions (2019-2020)
Table Global Parkinson's Disease Treatment Sales (K Unite) by Regions (2015-2020)
Table Global Parkinson's Disease Treatment CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Parkinson's Disease Treatment Sales Share by Regions (2019-2020)
Table Global Parkinson's Disease Treatment Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Parkinson's Disease Treatment CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Parkinson's Disease Treatment Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Parkinson's Disease Treatment
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Parkinson's Disease Treatment
Figure Cost Structure of Parkinson's Disease Treatment in 2020
Table Global Parkinson's Disease Treatment Capacity Share of Manufacturers (2019-2020)
Figure Global Parkinson's Disease Treatment Capacity Share of Manufacturers (2019-2020)
Table Global Parkinson's Disease Treatment Sales Market Share of Manufacturers (2019-2020)
Figure Global Parkinson's Disease Treatment Sales Market Share of Manufacturers (2019-2020)
Table Global Parkinson's Disease Treatment Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Parkinson's Disease Treatment Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Parkinson's Disease Treatment Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table Teva (Israel) Profiles
Table Teva (Israel) Parkinson's Disease Treatment Product Introduction
Table Teva (Israel) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Teva (Israel) SWOT Analysis
Table ????Novartis AG (Switzerland) Profiles
Table ????Novartis AG (Switzerland) Parkinson's Disease Treatment Product Introduction
Table ????Novartis AG (Switzerland) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Novartis AG (Switzerland) SWOT Analysis
Table ????GSK (UK) Profiles
Table ????GSK (UK) Parkinson's Disease Treatment Product Introduction
Table ????GSK (UK) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????GSK (UK) SWOT Analysis
Table ????AbbVie (US) Profiles
Table ????AbbVie (US) Parkinson's Disease Treatment Product Introduction
Table ????AbbVie (US) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????AbbVie (US) SWOT Analysis
Table ????Merck (US) Profiles
Table ????Merck (US) Parkinson's Disease Treatment Product Introduction
Table ????Merck (US) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Merck (US) SWOT Analysis
Table ????Boehringer Ingelheim (Germany) Profiles
Table ????Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Product Introduction
Table ????Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Boehringer Ingelheim (Germany) SWOT Analysis
Table ????Impax Laboratories (US) Profiles
Table ????Impax Laboratories (US) Parkinson's Disease Treatment Product Introduction
Table ????Impax Laboratories (US) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Impax Laboratories (US) SWOT Analysis
Table ????Lundbeck (Denmark) Profiles
Table ????Lundbeck (Denmark) Parkinson's Disease Treatment Product Introduction
Table ????Lundbeck (Denmark) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Lundbeck (Denmark) SWOT Analysis
Table ????UCB (Belgium) Profiles
Table ????UCB (Belgium) Parkinson's Disease Treatment Product Introduction
Table ????UCB (Belgium) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????UCB (Belgium) SWOT Analysis
Table ????Valeant Pharmaceuticals (Canada) Profiles
Table ????Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Product Introduction
Table ????Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Valeant Pharmaceuticals (Canada) SWOT Analysis
Table ????Acadia (US) Profiles
Table ????Acadia (US) Parkinson's Disease Treatment Product Introduction
Table ????Acadia (US) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Acadia (US) SWOT Analysis
Table ????Sun Pharma (India) Profiles
Table ????Sun Pharma (India) Parkinson's Disease Treatment Product Introduction
Table ????Sun Pharma (India) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Sun Pharma (India) SWOT Analysis
Table ????Wockhardt (India) Profiles
Table ????Wockhardt (India) Parkinson's Disease Treatment Product Introduction
Table ????Wockhardt (India) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Wockhardt (India) SWOT Analysis
Table ????Dr. Reddy's (India) Profiles
Table ????Dr. Reddy's (India) Parkinson's Disease Treatment Product Introduction
Table ????Dr. Reddy's (India) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Dr. Reddy's (India) SWOT Analysis
Table ????Intas (India) Profiles
Table ????Intas (India) Parkinson's Disease Treatment Product Introduction
Table ????Intas (India) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Intas (India) SWOT Analysis
Table ????US WorldMeds (US) Profiles
Table ????US WorldMeds (US) Parkinson's Disease Treatment Product Introduction
Table ????US WorldMeds (US) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????US WorldMeds (US) SWOT Analysis
Table ????Zydus Cadila (India) Profiles
Table ????Zydus Cadila (India) Parkinson's Disease Treatment Product Introduction
Table ????Zydus Cadila (India) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Zydus Cadila (India) SWOT Analysis
Table ????Cipla (India) Profiles
Table ????Cipla (India) Parkinson's Disease Treatment Product Introduction
Table ????Cipla (India) Parkinson's Disease Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Cipla (India) SWOT Analysis